{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:17:24Z","timestamp":1794565044935,"version":"4.9.1"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8645-16","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:10:31Z","timestamp":1507673431000},"page":"3327-3331","source":"Crossref","is-referenced-by-count":5,"title":["Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis"],"prefix":"10.2169","volume":"56","author":[{"given":"Masashi","family":"Namba","sequence":"first","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Postgraduate Medical and Dental Training Center, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Horimasu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Fujitaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Goncharova EA, Krymskaya VP. Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges. J Cell Biochem 103: 369-382, 2008."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Hayashida M, Seyama K, Inoue Y, Fujimoto K, Kubo K. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology 12: 523-530, 2007.","DOI":"10.1111\/j.1440-1843.2007.01101.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ellender CM, Williams TJ, Gooi J, Snell GI, Whitford HM. Management of refractory chylothorax in pulmonary lymphangioleiomyomatosis. Respirol Case Rep 3: 72-74, 2015.","DOI":"10.1002\/rcr2.105"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364: 1595-1606, 2011.","DOI":"10.1056\/NEJMoa1100391"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med 154: 797-805, 2011.","DOI":"10.7326\/0003-4819-154-12-201106210-00007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Harari S, Elia D, Torre O, Bulgheroni E, Provasi E, Moss J. Sirolimus therapy for patients with lymphangioleiomyomatosis leads to loss of chylous ascites and circulating LAM cells. Chest 150: e29-e32, 2016.","DOI":"10.1016\/j.chest.2016.02.654"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Barrera P, Simons SO, Luijk B, Wessels MJ, Heijdra YF. Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis. Ann Am Thorac Soc 10: 408-409, 2013.","DOI":"10.1513\/AnnalsATS.201212-125OC"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takagi Y, Sato T, Morio Y, et al. A pleuro-peritoneal communication through the diaphragm affected with lymphangioleiomyomatosis. Intern Med 49: 439-445, 2010.","DOI":"10.2169\/internalmedicine.49.2714"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40: 310-322, 2010.","DOI":"10.1016\/j.molcel.2010.09.026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Makino Y, Shimanuki Y, Fujiwara N, et al. Peritoneovenous shunting for intractable chylous ascites complicated with lymphangioleiomyomatosis. Intern Med 47: 281-285, 2008.","DOI":"10.2169\/internalmedicine.47.0475"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lefrou L, d'Alteroche L, Harchaoui Y, Franco D, Metman EH. Peritoneovenous shunt after failure of octreotide treatment for chylous ascites in lymphangioleiomyomatosis. Dig Dis Sci 52: 3188-3190, 2007.","DOI":"10.1007\/s10620-006-9353-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamaguchi H, Kitayama J, Emoto S, et al. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1. Eur J Surg Oncol 41: 875-880, 2015.","DOI":"10.1016\/j.ejso.2015.04.013"},{"key":"13","unstructured":"13. Takahashi Y, Takahashi R, Imai Y, et al. A case of lymphangioleiomyomatosis treated for controlling intractable chylothorax. Nihon Kokyuki Gakkai Zasshi (Ann Jpn Respir Soc) 7: 594-598, 2012 (in Japanese, Abstract in English)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Saitou H, Joshita S, Yoshizawa K, et al. A patient with liver cirrhosis stage hepatitis C having hepatocellular carcinoma and cervical cancer of the uterus treated by octreotide for chylous ascites. Kanzo (Liver) 54: 284-290, 2013 (in Japanese, Abstract in English).","DOI":"10.2957\/kanzo.54.284"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Swanson MS, Hudson RL, Bhandari N, Sinha UK, Maceri DR, Kokot N. Use of octreotide for the management of chyle fistula following neck dissection. JAMA Otolaryngol Head Neck Surg 141: 723-727, 2015.","DOI":"10.1001\/jamaoto.2015.1176"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ismail NA, Gordon J, Dunning J. The use of octreotide in the treatment of chylothorax following cardiothoracic surgery. Interact Cardiovasc Thorac Surg 20: 848-854, 2015.","DOI":"10.1093\/icvts\/ivv046"},{"key":"17","unstructured":"17. Kawakami T, Ishida I, Sugawara T, Oura H. The use of octreotide acetate in the management of refractory chylothorax following surgical treatment for lung cancer. Kyobu Geka (Jpn J Thorac Surg) 69: 429-432, 2016 (in Japanese, Abstract in English)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oishi H, Hoshikawa Y, Sado T, et al. A case of successful therapy by intrapleural injection of fibrin glue for chylothorax after lung transplantation for lymphangioleiomyomatosis. Ann Thorac Cardiovasc Surg 23: 40-44, 2017.","DOI":"10.5761\/atcs.cr.15-00319"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yetkin DO, Boysan SN, Tiryakioglu O, Yalin AS, Kadioglu P. Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotide. Endocri J 54: 459-464, 2007.","DOI":"10.1507\/endocrj.K06-100"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Paisley AN, Roberts ME, Trainer PJ. Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems. Clin Endocrinol 66: 723-726, 2007.","DOI":"10.1111\/j.1365-2265.2007.02811.x"},{"key":"21","unstructured":"21. Johnson SR, Tattersfield AE. Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med 160: 628-633, 1999."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kaira K, Iwasaki Y, Tsuchiya S, Saito R, Mori M. A case of postmenopausal lymphangioleiomyomatosis without signs of aggravation in the follow-up period. Kitakanto Med J 55: 161-163, 2005.","DOI":"10.2974\/kmj.55.161"},{"key":"23","unstructured":"23. Fukushima K, Hirosako S, Tenjin Y, et al. Pulmonary mucosa-associated lymphoid tissue lymphoma with spontaneous regression after computed tomography-guided needle biopsy: a case report and summary of 8 reported cases. Intern Med 55: 3655-3660, 2016."},{"key":"24","unstructured":"24. Everson TC, Cole WH. Spontaneous Regression of Cancer: A Study and Abstract of Reports in the World Medical Literature and of Personal Communications Concerning Spontaneous Regression of Malignant Disease. WB Saunders, Philadelphia, 1966: 3-10."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/24\/56_8645-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T06:01:34Z","timestamp":1659592894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/24\/56_8645-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8645-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}